Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genezen is a contract development and manufacturing organization (CDMO) specializing in the production of viral vectors for cell and gene therapies. The company provides a comprehensive range of services, including process development, analytical testing, and cGMP manufacturing for lentiviral and retroviral vectors. Genezen is distinguished by its proprietary Cyto-Gen platform, which utilizes stable producer cell lines to enhance the scalability and cost-effectiveness of vector production. Based in Indianapolis, the company operates state-of-the-art facilities designed to support biotechnology and pharmaceutical clients from early-stage clinical trials through commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genezen.